What's included
AI-assisted literature monitoring
AI pre-screens local and global journals, abstracts and databases, ranks articles by relevance and highlights possible ICSRs, special situations and signals. Our multilingual reviewers then assess every hit, so nothing is reported or rejected without a human decision.
AI-supported case processing
AI helps with ICSR intake: extracting reporter, patient, product and event data from emails, forms and source documents, suggesting MedDRA codes, spotting duplicates and drafting narratives. Case processors and medical reviewers check and complete each case before submission.
AI-powered regulatory intelligence
AI tracks authority websites, gazettes and guidelines in many languages, detects new and changed pharmacovigilance requirements and summarises them. Our regulatory experts rate the impact for your PV system and recommend actions.
Validation, data protection and compliance
Every AI step is documented, validated for its intended use and covered by our quality system, in line with GVP expectations and data protection law (GDPR and KVKK). Personal data stays within controlled, access-restricted systems.
Frequently asked questions
Does AI replace your pharmacovigilance experts?
No. AI speeds up screening, data extraction and monitoring, but qualified PV professionals review every output and remain responsible for each case, report and regulatory assessment.
Is AI use acceptable to regulators in pharmacovigilance?
Yes, when it is validated, documented and supervised. We keep a human in the loop, record how each tool is used and make this evidence available for audits and inspections.
